ARTICLE | Clinical News
InCode preclinical data
August 4, 2008 7:00 AM UTC
In primates, rC3-1 delivered directly to the pulmonary artery was well-tolerated and produced no adverse events. Data will be presented at the International Complement Workshop in Basel in September. ...